Xenon Pharmaceuticals Inc... (XENE)
NASDAQ: XENE
· Real-Time Price · USD
38.23
0.27 (0.71%)
At close: Aug 15, 2025, 3:59 PM
38.23
0.00%
After-hours: Aug 15, 2025, 04:42 PM EDT
Xenon Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 7.5M | n/a | n/a | n/a | n/a | 5.38M | n/a | n/a | n/a | 8.77K | 132K | 536K | 8.77M | 3.74M | 8.12M | 2.22M | 4.36M |
Cost of Revenue | n/a | n/a | n/a | 659K | 599K | 851K | 1.73M | 602K | 354K | 515K | 29.43M | 22.15M | 19.36M | 21.89M | 18.89M | 18.38M | 16.31M |
Gross Profit | n/a | n/a | n/a | -659K | -599K | 4.53M | -1.73M | -602K | -354K | -506.23K | -29.3M | -21.61M | -10.59M | -18.15M | -10.77M | -16.16M | -11.95M |
Operating Income | -72.74M | -77.48M | -73.68M | -69.1M | -59.04M | -53.7M | -55.68M | -55.62M | -49.05M | -43.33M | -38.13M | -30.32M | -17.37M | -24.84M | -15.6M | -22.5M | -16.06M |
Interest Income | 8.08M | 9.42M | 10.33M | 10.84M | 11.36M | 8.69M | 6.98M | 6.52M | 5.42M | 4.46M | 3.07M | 816K | 368K | 263K | 76K | 72K | 146K |
Pretax Income | -64.62M | -69.53M | -63.11M | -58.26M | -47.52M | -44.95M | -48.62M | -47.68M | -41.44M | -36.26M | -37.74M | -31.2M | -20.06M | -25.08M | -15.65M | -22.33M | -15.83M |
Net Income | -65.05M | -65.69M | -62.79M | -57.92M | -47.93M | -44.74M | -48.46M | -47.46M | -41.73M | -37.4M | -37.15M | -31.16M | -19.67M | -25.56M | -15.45M | -22.11M | -15.76M |
Selling & General & Admin | 19.04M | 18M | 16.71M | 19.4M | 14.19M | 11.77M | 12.8M | 11.58M | 9.54M | 8.5M | 8.83M | 8.71M | 6.78M | 6.69M | 4.83M | 6.34M | 4.11M |
Research & Development | 61.2M | 59.47M | 56.97M | 49.7M | 44.25M | 41.08M | 42.88M | 44.04M | 39.52M | 34.83M | 29.43M | 22.15M | 19.36M | 21.89M | 18.89M | 18.38M | 16.31M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 7.07M | 7.94M | n/a | 7.08M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 80.24M | 77.48M | 73.68M | 69.1M | 58.44M | 52.84M | 55.68M | 55.62M | 49.05M | 43.33M | 38.26M | 30.85M | 26.14M | 28.57M | 23.72M | 24.72M | 20.42M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 19K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -599K | -851K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 79.33M | 73.68M | 69.1M | 59.04M | 53.7M | 55.68M | 55.62M | 49.05M | 43.33M | 38.26M | 30.85M | 26.14M | 28.57M | 23.72M | 24.72M | 20.42M |
Income Tax Expense | -427K | -3.85M | -320K | -333K | 412K | -205K | -157K | -220K | 290K | 1.14M | -587K | -40K | -394K | 484K | -205K | -217K | -68K |
Shares Outstanding (Basic) | 78.69M | 78.39M | 77.93M | 77.67M | 77.59M | 69.97M | 66M | 65.86M | 65.72M | 65.66M | 62.54M | 56.19M | 53.06M | 41.19M | 41.19M | 42.09M | 36.82M |
Shares Outstanding (Diluted) | 78.69M | 78.39M | 77.93M | 77.67M | 77.59M | 69.97M | 66M | 65.86M | 65.72M | 65.66M | 65.47M | 56.19M | 54.85M | 41.19M | 42.27M | 42.09M | 36.82M |
EPS (Basic) | -0.83 | -0.84 | -0.81 | -0.75 | -0.62 | -0.64 | -0.73 | -0.72 | -0.63 | -0.57 | -0.59 | -0.55 | -0.37 | -0.62 | -0.37 | -0.53 | -0.43 |
EPS (Diluted) | -0.83 | -0.84 | -0.81 | -0.75 | -0.62 | -0.64 | -0.73 | -0.72 | -0.63 | -0.57 | -0.57 | -0.55 | -0.36 | -0.62 | -0.37 | -0.53 | -0.43 |
EBITDA | -72.74M | -76.84M | -73.01M | -68.44M | -58.44M | -52.84M | -53.95M | -55.02M | -48.7M | -41.05M | -37.77M | -29.94M | -16.99M | -24.81M | -15.39M | -22.27M | -15.86M |
EBIT | n/a | -69.53M | -73.68M | -69.1M | -59.04M | -53.7M | -55.68M | -55.62M | -49.05M | -39.44M | -38.13M | -30.32M | -17.37M | -25.08M | -15.6M | -22.5M | -16.06M |
Depreciation & Amortization | n/a | 633K | 669K | 659K | 599K | 851K | 1.73M | 602K | 354K | 515K | 358K | 375K | 376K | 270K | 209K | 231K | 196K |